FactaeThe Factual News

Novartis highlighted at the 2026 European Society of Cardiology congress

Novartis is presenting several innovations at the 2026 ESC congress, focusing on cardiovascular treatments.

Published 3j1 sourceupdated 3j
Lire en français
≈ 17s

The fact

The pharmaceutical group highlights its latest advances in gene therapies.

This participation strengthens its position in cardiovascular health.

Click the link to read an article on the topic:
Explore this topic
What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.
BarceloneWorld map →
Follow topic →
Auto-synthesis from 1 media source · identified on August 19, 2026
← Back to home
Discover

Read more

All marches →
marches

Novartis to present renal portfolio data in early June

12sem · 1 sourcemonde

Novartis revives growth despite losing patents on Entresto

4sem · 1 sourcemarches

Novartis prepares generic version of Sanofi's Lovenox

11sem · 1 sourcemarches

Novartis resists generic competition with rising profits

4sem · 1 source